Ex parte HANAOKA et al. - Page 3




          Appeal No. 94-3012                                                          
          Application 07/851,853                                                      


               The references relied on by the examiner are:                          
          Zee-Cheng et al.  (Zee-Cheng) (I)   3,912,740     Oct. 14, 1975             
          Zee-Cheng et al.  (Zee-Cheng) (II)   4,014,885    Mar. 29, 1977             

          Messmer et al. (Messmer), “Fagaronine, a New Tumor Inhibitor                
          Isolated from Fagara zanthoxyloides Lam. (Rutaceae),” Vol. 61,              
          No. 11, pp. 1858-1859, (Nov. 1972)                                          
          Hanaoka et al. (Hanaoka), “Synthesis of Fagaridine, A Phenolic              
          Benzo[c]phenanthridine Alkaloid,” Chem. Pharm. Bull., Vol. 33,              
          No. 4, pp. 1763-1765 (1985).                                                
          Ishii et al. (Ishii) (I), “Studies on the Chemical Constituents             
          of Rutaceous Plants. LX Development of a Versatile Method for               
          Syntheses of the Antitumor Benzo[c]phenanthridine Alkaloids.(9).            
          Efficient Syntheses and Antitumor Activities of Nitidine and                
          Related Nonphenolic Benzo[c]phenanthridine Alkaloids,” Chem.                
          Pharm. Bull, Vol. 33, No. 10, pp. 4139-4151 (1985).                         
          Ishii et al. (Ishii) (II), Chemical Abstracts, Vol. 107, No. 21,            
          pp. 799-800, Abstract No. 198705c (1987).                                   
          Kessar et al. (Kessar), “Benzyne Cyclization Route to                       
          Benzo[c]phenanthridine Alkaloids.  Synthesis of Chelerythrine,              
          Decarine, and Nitidine,” J. Org. Chem., Vol. 53, pp. 1708-1712,             
          (1988).                                                                     
               Claims 4, 5, 9, 10, 13, 14, 16 through 18 and 26 through 28            
          stand rejected under 35 U.S.C. § 103 as being unpatentable over             










                                          3                                           





Page:  Previous  1  2  3  4  5  6  7  8  9  10  Next 

Last modified: November 3, 2007